JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.20, no.3, pp.345-349, 2001 (SCI-Expanded)
The purpose of this study was to verify the kinetic response of the human marrow myeloid progenitor cells to the short term use of GM-CSF and its impact on the therapeutic activity of this three-drug cisplatinum containing regimen in non small cell lung cancer (NSCLC).